David Einhorn acquired 1.27 Million Coya Therapeutics shares worth $10.7 Million. That's 0.48% of their equity portfolio (25th largest holding). The investor owns 15.42% of the outstanding Coya Therapeutics stock. The stake costed the investor $6.6 Million, netting the investor a gain of 62% so far.